Retinal Vascular Disease Take-Home Panel

Related

• 

  48-Week End of Study Results From BEHOLD Phase 2 Study of UBX1325 in Patients With DME

  Arshad M. Khanani, MD, MA, FASRS

  Annual Meeting Talks

  2023

• 

  Vision Threatening Complications in Patients With Diabetic Macular Edema: A Post Hoc Analysis of the VISTA and VIVID Trials

  Diana V Do, MD, FASRS

  Annual Meeting Talks

  2019

• 

  Are There Safety Concerns With Bevacizumab for ROP

  Robert L. Avery, MD

  Updates from the Field

  2017